Category: Consumer goods
Quick infos Headquarters: Menlo Park, California, United States Trade prices Volume: Market Cap: 527.89M Prev closed: Open: High: Low: 52 week low: 52 week high: Dividends: Next ER: November 3, 2022 Before Market Opens
Earnings History Date EPS / Forecast Revenue / Forecast March 9, 2023 November 3, 2022 -0.1 / -0.1297K / 114.6KBeat! August 11, 2022 -0.07 / -0.09473K / 114.6KMay 9, 2022 -0.09 / -0.102123K / 102.25KBeat! March 10, 2022 -0.1 / -0.0841.04M / 77.25Kview more
Historical Data Date Price Open High Low Vol Change ER Aug 11, 2022 2.0500 2.1500 2.2400
2.0150
3.45M -5.53% Aug 10, 2022 2.1700 2.1100 2.2000
2.0000
4.18M 4.83% Aug 9, 2022 2.0700 2.1900 2.2200
2.0200
4.37M -7.59% Aug 8, 2022 2.2400 2.4600 2.5400
2.1750
6.80M -7.44% Aug 5, 2022 2.4200 2.3750 2.5100
2.3100
6.12M -1.63% Aug 4, 2022 2.4600 2.0600 2.6700
2.0400
13.62M 20.59% Aug 3, 2022 2.0400 1.9600 2.0700
1.9500
4.22M 5.15% Aug 2, 2022 1.9400 1.8700 1.9600
1.8450
1.49M 4.30% Aug 1, 2022 1.8600 1.8800 1.9300
1.8400
1.65M -2.11% Jul 29, 2022 1.9000 1.9900 1.9900
1.8800
1.76M -3.55% view more
News
Geron EPS in-line, beats on revenue seekingalpha.com Aug 17, 2021 4:07 am Geron shares shoot up 51% on phase 2 data for myelofibrosis candidate seekingalpha.com Jun 19, 2021 12:31 am Geron, AnPac Bio-Medical Science leads healthcare gainers; Orphazyme, Athira Pharma among major losers seekingalpha.com Jun 18, 2021 11:01 pm
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Geron Corporation (GERN) Investors: 11-Day Application Deadline Approaching, Investors with Losses Encouraged to Contact Firm finance.yahoo.com Aug 13, 2020 6:35 pm
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Geron Corporation (GERN) Investors: 7 Days Remain Until Application Deadline, Investors with Losses Encouraged to Contact Firm finance.yahoo.com Aug 13, 2020 6:25 pm
CLASS ACTION UPDATE for GERN, AAN and MGPI: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders finance.yahoo.com Aug 13, 2020 4:55 pm Geron surges after publication of IMbark Phase 2 data seekingalpha.com Jun 18, 2021 11:22 am Geron EPS misses by $0.01, beats on revenue seekingalpha.com May 11, 2021 4:06 am Geron starts dosing in late-stage blood cancer study seekingalpha.com Apr 13, 2021 7:41 pm Geron EPS in-line, beats on revenue seekingalpha.com Mar 12, 2021 5:17 am Geron launches late-stage imetelstat study in refractory myelofibrosis seekingalpha.com Dec 11, 2020 10:03 pm Geron EPS in-line, beats on revenue seekingalpha.com Nov 6, 2020 5:16 am Geron secures up to $75M non-dilutive financing seekingalpha.com Oct 2, 2020 4:37 am
Geron Corporation Reports First Quarter 2020 Financial Results finance.yahoo.com Aug 13, 2020 4:05 pm
Geron Announces Plans for Imetelstat Phase 3 Clinical Trial in Myelofibrosis and Other Updates finance.yahoo.com Aug 13, 2020 4:01 pm
SHAREHOLDER ALERT: GERN TVTY CRON: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines finance.yahoo.com Aug 13, 2020 2:45 pm
Geron Corp. to Host Earnings Call finance.yahoo.com Aug 13, 2020 2:30 pm
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of GERN, ALGN and CRON finance.yahoo.com Aug 13, 2020 1:45 pm
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of GERN, CAN and TLRY finance.yahoo.com Aug 13, 2020 1:05 pm
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of GERN, JELD and CRON finance.yahoo.com Aug 13, 2020 12:30 pm Key Persons CEO : John A Scarlett (Sep 2011–) Talk about Geron Corp below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Want to know the strategies of successful swing trading? This friendly guide covers the ins and outs of this risky but profitable investing approach, explaining all the basics in plain English. You'll see how to use the two investment approaches - technical and fundamental analysis - to indentify promising securities in strongly trending markets. In addition, this guide covers how to calculate investment returns and, most important, how to manage your portfolio's risk.
Take advantage of price swings in strongly trending securities and pump up your portfolio!
